epilepsy

VALPARIN CHRONO 300/500 (Sodium Valproate and Valporic acid)

VALPARIN CHRONO 300/500 (Sodium Valproate and Valporic acid)

Valproate exerts its effects primarily on the central nervous system. Its anticonvulsant properties are exerted against a wide variety of epilepsies experimental animal models and humans. Its main mechanism of action seems to be related to reinforcement of the gabanergic pathways.

Zarontin ® (Ethosuximide Capsules, USP)

Zarontin ® (Ethosuximide Capsules, USP)

Ethosuximide suppresses the paroxysmal three cycle per second spike and wave activity associated with lapses of consciousness which is common in absence (petit mal) seizures. The frequency of epileptiform attacks is reduced, apparently by depression of the motor cortex and elevation of the threshold of the central nervous system to convulsive stimuli.

Depakote (divalproex sodium) delayed-release tablets

Depakote (divalproex sodium) delayed-release tablets

Divalproex sodium is a stable co-ordination compound comprised of sodium valproate and valproic acid in a 1:1 molar relationship. Divalproex sodium dissociates to the valproate ion in the gastrointestinal tract. The mechanisms by which valproate exerts its therapeutic effects have not been established.